Earnings Outlook For Champions Oncology
Portfolio Pulse from Benzinga Insights
Champions Oncology (NASDAQ:CSBR) is set to release its latest quarterly earnings report on September 13, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a trend of missing EPS estimates, which has led to negative stock price changes. The company's shares are currently trading at $6.61, down 15.04% over the last 52-week period.
September 12, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Champions Oncology is expected to report an EPS of $-0.10 in its upcoming earnings report. The company's history of missing EPS estimates and the resulting negative stock price changes could potentially impact the stock negatively.
Champions Oncology has a history of missing EPS estimates, which has led to negative stock price changes. Given this trend and the analysts' estimate of a negative EPS for the upcoming report, it is likely that the stock price may be negatively impacted in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100